News
-
-
PRESS RELEASE
Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero
Transgene strengthens Scientific Advisory Board with renowned cancer immunotherapy experts Prof. Antoine Italiano and Prof. Ignacio Melero. Appointment to accelerate development of myvac® platform and viral vector-based cancer vaccines -
-
-
-
-
-
-
PRESS RELEASE
GURIT REPORTS NET SALES OF CHF 319.6 MILLION FOR THE CALENDAR YEAR 2025 AND EXPECTS MARGIN TO IMPROVE VERSUS 2024.
Gurit reports preliminary net sales of CHF 319.6 million for 2025, driving progress in transformation and securing contracts with strategic customers. Margin expected to improve in 2026 -
PRESS RELEASE
HBM Healthcare Investments publishes Quarterly Report as at 31 December 2025 with key figures for the first nine months of the 2025/2026 financial year
HBM Healthcare Investments publishes positive Q3 results, with CHF 191 million profit, 18% NAV increase, and new private company investments